文献速递消化内镜消化道出血

医生与患者依从性对结肠镜息肉切除抗血栓治疗结局的影响

Impact of Physicians' and Patients' Compliance on Outcomes of Colonoscopic Polypectomy With Anti-Thrombotic Therapy.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-09-12

前瞻性纳入602例服用抗血栓药物行结肠镜息肉切除术的患者,评估医生对2018年亚太胃肠病学协会-亚太消化内镜学会实践指南的依从性及患者依从性。医生对阿司匹林、氯吡格雷、双联抗血小板、华法林和直接口服抗凝药的依从率分别为98.4%、41.2%、40.0%、8.5%和5.2%;患者依从率分别为74.8%、41.2%、0%、36.2%和17.5%。医生不依从指南是迟发性息肉切除后出血(调整HR 3.54)和严重心血管事件(HR 15.63)的风险因素。

要点

  • 医生对阿司匹林依从率98.4%,对氯吡格雷41.2%、双联抗血小板40.0%、华法林8.5%、直接口服抗凝药5.2%。
  • 患者对阿司匹林、氯吡格雷、双联抗血小板、华法林、直接口服抗凝药的依从率分别为74.8%、41.2%、0%、36.2%、17.5%。
  • 医生不依从指南与迟发性息肉切除后出血(调整HR 3.54)和严重心血管事件(HR 15.63)相关。

核心结论

  • 除阿司匹林外,医生对指南的依从性和患者依从性均较差,并导致不良临床结局。

研究设计与样本

  • 前瞻性研究,在一家三级转诊中心连续招募2017年12月至2019年10月期间服用抗血栓药物并接受择期结肠镜息肉切除术的患者602例。

主要发现

  • 医生对阿司匹林、氯吡格雷、双联抗血小板治疗、华法林和直接口服抗凝药的指南依从率分别为98.4%、41.2%、40.0%、8.5%和5.2%。
  • 患者对阿司匹林、氯吡格雷、双联抗血小板治疗、华法林和直接口服抗凝药的依从率分别为74.8%、41.2%、0%、36.2%和17.5%。
  • 医生不依从指南是迟发性息肉切除后出血的风险因素(调整HR 3.54;95%CI 1.46-8.58;P=0.005)。
  • 医生不依从指南是严重心血管事件的风险因素(HR 15.63;95%CI 1.83-133.80;P=0.012)。

关键数值与推荐

  • 采用2018年亚太胃肠病学协会-亚太消化内镜学会实践指南,并假定临床医生应在所有结肠镜患者的息肉切除术中停用抗血栓药物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Although there are international guidelines on the management of antithrombotic therapy in patients undergoing colonoscopic polypectomy, whether clinicians and patients follow these recommendations are largely unknown. We aimed to evaluate clinician adherence and patient compliance to periendoscopic management of antithrombotic therapy and their impact on clinical outcomes. METHODS: Consecutive patients on antithrombotic therapy scheduled for elective colonoscopy in a tertiary referral center were recruited prospectively. Demographic data, indications and periprocedural management of antithrombotic drugs, colonoscopy findings, postpolypectomy bleeding, and serious cardiovascular events were collected systematically. We used Joint Asian Pacific Association of Gastroenterology-Asian Pacific Society for Digestive Endoscopy Practice Guidelines 2018 and assumed clinicians should hold antithrombotics for polypectomy in all colonoscopy patients. Patient compliance was assessed by checking whether discontinuation and resumption of antithrombotic drugs were in accordance with clinician advice. RESULTS: Between December 2017 and October 2019, there were 602 patients recruited who were on antithrombotic drugs undergoing colonoscopy with polypectomy. A total of 98.4%, 41.2%, and 40.0% of clinicians adhered to the guidelines for aspirin alone, clopidogrel alone, and dual-antiplatelet therapy, respectively. Adherence rates were 8.5% for warfarin and 5.2% for direct oral anticoagulants. Compliance to instructions for aspirin alone, clopidogrel alone, dual-antiplatelet therapy, warfarin, and direct oral anticoagulants were achieved in 74.8%, 41.2%, 0%, 36.2%, and 17.5% of patients, respectively. Clinician nonadherence to guidelines was a risk factor for delayed postpolypectomy bleeding (adjusted hazard ratio, 3.54; 95% CI, 1.46-8.58; P = .005), and serious cardiovascular events (hazard ratio, 15.63; 95% CI, 1.83-133.80; P = .012). CONCLUSIONS: Physician adherence to the guideline and patient compliance, with the exception of aspirin, were poor and contributed to adverse clinical outcomes. ClinicalTrials.gov number: NCT03363061.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Jiang W, Suen BY, Ho HT, et al. Impact of Physicians' and Patients' Compliance on Outcomes of Colonoscopic Polypectomy With Anti-Thrombotic Therapy. Clin Gastroenterol Hepatol. 2020. PMID: 32931958. doi:10.1016/j.cgh.2020.09.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。